Summary & Overview
HCPCS Q4263: Surgraft per Square Centimeter, Add-On
HCPCS Level II code Q4263 designates a surgraft product billed per square centimeter as an add-on supply in addition to a primary surgical procedure. This code applies to biologic graft material used in operative settings and matters for accurate product-level billing, inventory tracking, and aggregate reporting of graft usage across surgical specialties. Nationally, precise reporting of add-on graft products supports reimbursement transparency and clinical supply chain management.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical role and billing context, an overview of payer coverage considerations, and what typical claims lines using Q4263 represent. The publication summarizes benchmark concepts, common modifiers associated with add-on supplies, and the typical sites of service where Q4263 is applied. Policy updates affecting add-on HCPCS supply reporting and implications for surgical billing workflows are highlighted. Where specific input fields are missing, the report states the absence of that data rather than infers details.
Billing Code Overview
HCPCS Level II code Q4263 represents Surgraft tissue-per-square-centimeter, billed as an add-on that is listed separately in addition to a primary procedure. The code denotes a biologic graft product measured and billed by square centimeter for use in surgical procedures.
Service Type: Graft product / surgical implant supply
Typical Site of Service: Hospital operating room, ambulatory surgery center, or other surgical setting where grafting is performed
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related procedure codes.
Clinical & Coding Specifications
Clinical Context
A patient with a full-thickness or deep partial-thickness skin defect after traumatic avulsion of the lower extremity presents to a reconstructive surgery clinic. The wound bed has been debrided, and the surgical team plans a dermal regeneration template application using SurgiFIt (dermal graft substitute) billed by surface area. The primary procedure is autologous skin grafting or flap coverage; Q4263 is reported as an add-on per square centimeter in addition to the primary procedure. Typical workflow: preoperative evaluation and wound measurement, intraoperative debridement and preparation of the recipient bed, harvesting of autograft if required, application and fixation of the dermal graft material sized and documented in cm2, and postoperative dressings and follow-up visits to monitor graft take and wound healing. Typical sites of service include outpatient ambulatory surgery centers and inpatient operating rooms for complex wounds. Typical patient scenarios include traumatic wounds, chronic nonhealing ulcers after vascular insufficiency or diabetes when a dermal substitute is used to augment grafting, and reconstruction after oncologic resection of skin and soft tissue.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Used when no billing modifier is applicable for the service |